Dark Web has become a marketplace for ‘vaccines’ and other pandemic scams


In the first months of the pandemic, vendors mostly specialised in hard-to-find Covid commodities. More recently, dark web profiteers have offered so-called vaccines for those unwilling to wait for final government approvals. — Pixabay

Following Donald Trump’s quick recovery from Covid-19 last month, advertisements appeared on the dark web – the seamy underbelly of the Internet – selling what they claimed was Regeneron Pharmaceuticals Inc’s drug that the president touted as a ‘miracle’ cure – even though it hadn’t yet been approved for public sale.

In May, with coronavirus cases surging around the world and no end in sight, a supposed Spanish laboratory doctor promised Covid-19 infected blood and sputum. It wasn’t clear if it was offered because it might contain protective antibodies or as a way to infect an unwitting enemy. Either way the price for the treatment was US$100 (RM402) for two syringes.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Tech News

Smartphone on your kid’s Christmas list? How to know when they’re ready.
A woman's Waymo rolled up with a stunning surprise: A man hiding in the trunk
A safety report card ranks AI company efforts to protect humanity
Bitcoin hoarding company Strategy remains in Nasdaq 100
Opinion: Everyone complains about 'AI slop,' but no one can define it
Google faces $129 million French asset freeze after Russian ruling, documents show
Netflix’s $72 billion Warner Bros deal faces skepticism over YouTube rivalry claim
Pakistan to allow Binance to explore 'tokenisation' of up to $2 billion of assets
Analysis-Musk's Mars mission adds risk to red-hot SpaceX IPO
Analysis-Oracle-Broadcom one-two punch hits AI trade, but investor optimism persists

Others Also Read